XERIS BIOPHARMA HOLDINGS, INC. Weighted Average Number of Shares Issued, Basic
XERIS BIOPHARMA HOLDINGS, INC. (XERS) reported Weighted Average Number of Shares Issued, Basic of 79.03 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2024-03-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesIssuedBasic · last filed 2024-03-06
- XERIS BIOPHARMA HOLDINGS, INC. weighted average number of shares issued, basic for fiscal 2021 was 79.03M shares.
| Period end | Weighted Average Number of Shares Issued, Basic 12 month |
|---|---|
| 2021-12-31 | 79.03M shares 10-K · filed 2024-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |